Clinical implications of persisting preleukemic clones in remission in acute myeloid leukemia (AML)
An overview of the current treatment landscape of non-Hodgkin lymphoma
PET-CT vs MRI in multiple myeloma
Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
The clinical implications of progenitor cells in multiple myeloma
Gareth Morgan et al.